HR
GNCA

Howe & Rusling’s Genocea Biosciences, Inc. GNCA Stock Holding History

Howe & Rusling’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10
Closed – – 1172
2016
Q2 		$0 Hold
10
– – ﹤0.01% 1086
2016
Q1 		$1K Hold
10
– – ﹤0.01% 980
2015
Q4 		$0 Hold
10
– – ﹤0.01% 1109
2015
Q3 		$1K Hold
10
– – ﹤0.01% 991
2015
Q2 		$1K Buy
+10
New +$928 ﹤0.01% 1013

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Howe & Rusling's GNCA Position: Q3 2016 in Review

Howe & Rusling sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2016, closing a stake of 10 shares.

Howe & Rusling first reported a position in GNCA in Q2 2015 and held it in 5 quarters. The position peaked at $1K in Q1 2016. 48 funds tracked by Wall St. Rank hold GNCA as of Q3 2016.

  • Howe & Rusling reported no remaining Genocea Biosciences, Inc. position as of Q3 2016 after selling out during the quarter.
  • Howe & Rusling sold 10 Genocea Biosciences, Inc. shares in Q3 2016.
  • Howe & Rusling first reported a position in Genocea Biosciences, Inc. in Q2 2015 and held it in 5 quarters.
  • Howe & Rusling's Genocea Biosciences, Inc. position peaked at $1K in Q1 2016.
  • 48 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2016.

Based on Howe & Rusling's 13F filing for Q3 2016, filed 17 Oct 2016.